Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hays

Showing results (281-290 of 584) with videos related to

Pageof 59
Sort By:
The American Journal of Physiology|September 1, 1984
Electron-microscopic study of the apical region of the toad bladder epithelial cellJ Sasaki, S Tilles, J Condeelis, et al.
Cancer|April 1, 1993
Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study CommitteeB Raney, R Heyn, D M Hays, et al.
Regulatory Toxicology and Pharmacology : RTP|June 27, 2026
Consideration of Carcinogenicity and Mode of Action Information by an Independent Expert Panel to Support Derivation of No-Significant-Risk-Level Values for Vinyl Acetate MonomerC R Kirman, W Dekant, V L Dellarco, et al.
The Journal of Biological Chemistry|January 26, 1996
Microtubular disruption prolongs the expression of human bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 gene transferred into Gunn rat liversN R Chowdhury, R M Hays, V R Bommineni, et al.
Journal of Pediatric Surgery|May 1, 1988
An evaluation of the role of surgery in metastatic neuroblastomaM Matsumura, J B Atkinson, D M Hays, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 19, 2007
A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effectsJ S Lakind, S T Holgate, D R Ownby, et al.
Critical Reviews in Toxicology|June 9, 2026
Evaluation of the modes of action for key noncancer effects of 1,3-Butadiene: input from an independent expert panel to support derivation of data-derived extrapolation factorsChristopher R Kirman, John C Lipscomb, John Rogers, et al.
Medical and Pediatric Oncology|January 1, 1975
The influence of chemotherapy on the prognosis of rhabdomyosarcomaJ A Ortega, G E Rivard, H Isaacs, et al.
American Journal of Public Health|September 18, 2015
A Randomized Comparative Effectiveness Trial for Preventing Type 2 DiabetesRonald T Ackermann, David T Liss, Emily A Finch, et al.
Regulatory Toxicology and Pharmacology : RTP|January 28, 2024
Derivation of no significant risk levels for three lower acrylates: Conclusions and recommendations from an expert panelC R Kirman, P J Boogaard, J S Bus, et al.
Pageof 59

Showing results (281-290 of 584) with videos related to

Sort By:
Pageof 59
The American Journal of Physiology|September 1, 1984
Electron-microscopic study of the apical region of the toad bladder epithelial cellJ Sasaki, S Tilles, J Condeelis, et al.
Cancer|April 1, 1993
Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study CommitteeB Raney, R Heyn, D M Hays, et al.
Regulatory Toxicology and Pharmacology : RTP|June 27, 2026
Consideration of Carcinogenicity and Mode of Action Information by an Independent Expert Panel to Support Derivation of No-Significant-Risk-Level Values for Vinyl Acetate MonomerC R Kirman, W Dekant, V L Dellarco, et al.
The Journal of Biological Chemistry|January 26, 1996
Microtubular disruption prolongs the expression of human bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 gene transferred into Gunn rat liversN R Chowdhury, R M Hays, V R Bommineni, et al.
Journal of Pediatric Surgery|May 1, 1988
An evaluation of the role of surgery in metastatic neuroblastomaM Matsumura, J B Atkinson, D M Hays, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 19, 2007
A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effectsJ S Lakind, S T Holgate, D R Ownby, et al.
Critical Reviews in Toxicology|June 9, 2026
Evaluation of the modes of action for key noncancer effects of 1,3-Butadiene: input from an independent expert panel to support derivation of data-derived extrapolation factorsChristopher R Kirman, John C Lipscomb, John Rogers, et al.
Medical and Pediatric Oncology|January 1, 1975
The influence of chemotherapy on the prognosis of rhabdomyosarcomaJ A Ortega, G E Rivard, H Isaacs, et al.
American Journal of Public Health|September 18, 2015
A Randomized Comparative Effectiveness Trial for Preventing Type 2 DiabetesRonald T Ackermann, David T Liss, Emily A Finch, et al.
Regulatory Toxicology and Pharmacology : RTP|January 28, 2024
Derivation of no significant risk levels for three lower acrylates: Conclusions and recommendations from an expert panelC R Kirman, P J Boogaard, J S Bus, et al.
Pageof 59